Successful emicizumab prophylaxis in treatment-refractory acquired von Willebrand syndrome associated with rheumatoid arthritis

An article created on 2026-10-21 15:01:40

#	Наименование новости	Информативность	Дата публикации
1	Real-world outcomes after rituximab and abatacept initiation in rheumatoid arthritis: a retrospective single-centre cohort study	24.29	21-10-2026
2	A Novel Homozygous Canonical Splice-Donor VWF Variant Causing Type 3 von Willebrand Disease in an Iranian Patient: Case Report	20.74	21-10-2026
3	Resveratrol Modulates Inflammatory Gene Expression in LPS Stimulated HMC3 Microglia	22.5	21-10-2026
4	Construction and validation of an early diagnostic model for venous thromboembolism in elderly patients	13.78	10-08-2026
5	Human Plasma Causal Immunome-Phenome Mapping Reveals Cardiovascular Enrichment and Therapeutic Target Opportunities	21.11	21-10-2026
6	Adjuvant optimization and protective efficacy evaluation of scuticociliate vaccine	16.67	21-10-2026
7	Probiotic extracellular vesicles loaded with multifunctional nanozymes for inflammatory bowel disease treatment	15.56	10-08-2026
8	Cerebral Venous Thrombosis Following Varicella Zooster Infection: Case Report	5	16-07-2026
9	High-efficiency Expression and Application of Anti-p53 Recombinant Antibodies in CHO Cells	27.65	21-10-2026
10	Individual Cardiometabolic Risk Factors and Long-Term Cardiovascular Outcomes in Metabolic Dysfunction-Associated Steatotic Liver Disease	25	22-10-2026

Классификация: Информация. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 20.53. Источник: www.researchsquare.com.

Найдите то, что Вас интересует